Search results
I Took Mushrooms at a Death Grips Show. It Might Have Cured My ADHD.
Esquire· 2 days agoUnderstanding what happened to my brain after a psilocybin experience—and what it means for ...
RM's ‘Right Place, Wrong Person’ Is a Dynamic and Exciting Offering: Review
HYPEBEAST· 1 day agoThe 11-track album clocks in at an easy 35 minutes and arrives about a year and a half after the BTS...
Make college commencements boring again
Fox News· 2 days agoNEWYou can now listen to Fox News articles! During his commencement address this month at my alma mater, Ohio State, Chris Pan admitted that he took ...
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Motley Fool via Yahoo Finance· 4 days agoAs a psychedelic therapy developer, Compass Pathways (NASDAQ: CMPS) is on the cutting edge of...
In Saudi Arabia, an all-women psychedelic rock band jams outs as its conservative society loosens up
Associated Press via Yahoo News· 5 days agoLeaning into the microphone in Saudi Arabia's capital, Nora let loose a primal scream. The...
I Took Mushrooms at a Death Grips Show. It Might Have Cured My ADHD.
Esquire via AOL· 2 days agoThings went sideways about thirty minutes in. I am no stranger when it comes to psychedelics—I mean,...
Fluence Launches Generative AI Tools for Psychedelic Therapist Training
PRWeb· 3 days ago"Our partnership with Metamorph AI represents a significant step forward in the field of psychedelic therapy training," said Ingmar Gorman, Ph.D., Fluence co-founder and CEO ...
Nicole Shanahan walked away with more than $1B after divorcing Google co-founder Sergey Brin: report
NY Post via Yahoo News· 2 days agoDuring their five-year marriage, Shanahan attended parties with other tech executives in Silicon...
In Saudi Arabia, an all-women psychedelic rock band jams out as its conservative society loosens up
Houston Chronicle· 5 days agoLeaning into the microphone in Saudi Arabia's capital, Nora let loose a primal scream. The...
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring | The Motley Fool
The Motley Fool· 4 days agoAs a psychedelic therapy developer, Compass Pathways (CMPS -0.63%) is on the cutting edge of...